Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” ...

Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research ...

It’s been a bad month for the stock market. But it’s been a terrible month—in fact, a terrible year—for Tesla. Even after ...

Various factors have weighed on tech stocks this year, including investor unease over Trump's tariffs and AI spending.

Tesla’s stock began rising from the opening Tuesday after Trump posted overnight on his Truth Social platform that Musk was “putting it on the line” to help the country. Trump claimed in the post that ...

Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company posted underwhelming ...

Wedbush analyst Daniel Ives maintained a Buy rating on Paymentus Holdings (PAY – Research Report) today and set a price target of $38.00. The ...

As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...

AMC is also in a good position for continued growth, Hickey wrote in a note earlier this month. Benchmark has a hold rating for the movie-theater chain and original meme stock. In a separate note, the ...

Musk has become the face of the Trump administration’s slash-and-burn government downsizing efforts, known as the Department ...

It was an extraordinary scene at the White House South Lawn Tuesday. President Donald Trump effectively held a combination ...